Document Detail

Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin.
MedLine Citation:
PMID:  9413345     Owner:  NLM     Status:  MEDLINE    
We present a 28-year-old primigravida woman in whom congestive heart failure developed 3 months after delivery of a neonate. The patient underwent doxorubicin treatment 10 years previously. The combined cardiotoxicity of prior doxorubicin treatment and pregnancy is considered, and the importance of careful follow-up of cardiac function during pregnancy and postpartum in patients previously treated with doxorubicin is stressed.
A Katz; I Goldenberg; C Maoz; M Thaler; E Grossman; T Rosenthal
Related Documents :
24778445 - Maternal kir in combination with paternal hla-c2 regulate human birth weight.
24969365 - Inferences of body energy reserves on conception rate of suckled zebu beef cows subject...
24007705 - Visceral adiposity in the first half of pregnancy predicts newborn weight among adolesc...
24884985 - No global consensus: a cross-sectional survey of maternal weight policies.
17167825 - Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications.
11368405 - Identification of cripto-1 in human milk.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The American journal of the medical sciences     Volume:  314     ISSN:  0002-9629     ISO Abbreviation:  Am. J. Med. Sci.     Publication Date:  1997 Dec 
Date Detail:
Created Date:  1998-01-16     Completed Date:  1998-01-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370506     Medline TA:  Am J Med Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  399-400     Citation Subset:  AIM; IM    
Department of Internal Medicine D, The Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibiotics, Antineoplastic / adverse effects*,  therapeutic use
Cardiomyopathy, Dilated / chemically induced*,  therapy
Doxorubicin / adverse effects*,  therapeutic use
Puerperal Disorders / chemically induced*
Time Factors
Reg. No./Substance:
0/Antibiotics, Antineoplastic; 23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pheochromocytoma crisis caused by contemporary ergotamine, caffeine, and nimesulide administration.
Next Document:  Recovery of pancreatic beta-cell function in hemochromatosis: combined treatment with recombinant hu...